Fig. 1From: Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosisFlowchart of the study population inclusion. IPF: idiopathic pulmonary fibrosisBack to article page